PMV Pharmaceuticals, Inc. - Common Stock, $0.00001 par value per share (PMVP)

Q: What does CUSIP 69353Y103 represent in this 13F holders report?

CUSIP 69353Y103 is the security identifier for PMVP - PMV Pharmaceuticals, Inc. - Common Stock, $0.00001 par value per share used to aggregate holder disclosures.

Q: How many institutions held PMVP - PMV Pharmaceuticals, Inc. - Common Stock, $0.00001 par value per share in Q2 2022?

105 institutional investors reported PMVP - PMV Pharmaceuticals, Inc. - Common Stock, $0.00001 par value per share for Q2 2022. Use the holders table for investor-level position and value details.

CUSIP: 69353Y103

Q2 2022 13F Holders as of 30 Jun 2022

Security type / class: Equity / Common Stock, $0.00001 par value per share
Total 13F shares: 61,123,657
Total 13F value: $870,921,498
Share change: +5,912,520
Put/Call ratio: 34%
SEC-reported price per share: $14.25
Number of holders: 105
Value change: +$53,476,878
Number of buys: 75
Number of sells: 32
Shares outstanding: 76,540,071

Security key

69353Y103

Report period

Q2 2022

Institutions

105

Top holders

PMVP full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2025 PMV Pharmaceuticals, Inc. SEC filings PMV Pharmaceuticals, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 69353Y103

Newer quarter: Q3 2025

Recent filing periods:

Q3 2026 Q3 2025

Ownership snapshot

Top reported holders of PMVP - PMV Pharmaceuticals, Inc. - Common Stock, $0.00001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Euclidean Capital LLC

Disclosed value leader

ORBIMED ADVISORS LLC

Comparable rows

0/15

Latest evidence

31 Mar 2022

13F 3/4/5 Highest disclosed value: $142,730,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

ORBIMED ADVISORS LLC has the largest disclosed position value at $142.73M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ORBIMED ADVISORS LLC's linked filing trail.

Disclosed position value Top 5

Euclidean Capital LLC $48.65M

INTERWEST PARTNERS X LP $10.04M

ORBIMED ADVISORS LLC $142.73M

MORGAN STANLEY $91.38M

RTW INVESTMENTS, LP $80.62M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Euclidean Capital LLC	13F 3/4/5 Company · 10%+ Owner 13F 3/4/5	— denominator unverified	$48,654,000 2,336,909 shares	—	31 Mar 2022
INTERWEST PARTNERS X LP	3/4/5 10%+ Owner 3/4/5	— denominator unverified	$10,040,531 4,502,480 shares	—	13 Jul 2021
Peter A. Thompson	3/4/5 Director, 10%+ Owner 3/4/5	— denominator unverified	— 16,333 shares	—	02 Jun 2021
ORBIMED ADVISORS LLC	13F Company 13F	— denominator unverified	$142,730,000 6,855,423 shares	—	31 Mar 2022
MORGAN STANLEY	13F Company 13F	— denominator unverified	$91,381,000 4,389,070 shares	—	31 Mar 2022
RTW INVESTMENTS, LP	13F Company 13F	— denominator unverified	$80,618,000 3,872,154 shares	—	31 Mar 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

105

61,123,657

Rows available

105

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2022 vs Q3 2025 Across Filers

Q3 2025 holders

Q2 2022 holders

105

Holder diff

Investor	Q3 2025 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q3 2025 value	Q2 2022 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend